Used in the synthesis of prostaglandin analogs, particularly in ophthalmic medications for treating glaucoma. It serves as a key chiral intermediate in the production of drugs like tafluprost, which reduce intraocular pressure by enhancing uveoscleral outflow of aqueous humor. Its rigid cyclopropyl structure contributes to metabolic stability and receptor selectivity, making it valuable in developing potent, long-acting ophthalmic agents. Also employed in research for designing bioactive molecules with improved pharmacokinetic profiles.